A central role for Pyk2-Src interaction in coupling diverse stimuli to increased epithelial NBC activity

Doris Joy D. Espiritu1,2, Angelito A. Bernardo1,2, R. Brooks Robey1,2,3, and Jose A. L. Arruda1,2,3

1 Section of Nephrology, Department of Medicine, University of Illinois at Chicago, Chicago 60612 - 7315; 3 Department of Physiology and Biophysics, College of Medicine, University of Illinois at Chicago, Chicago 60612 - 7342; and 2 West Side Division, Veterans Administration Chicago Health Care System, Chicago, Illinois 60612


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Regulation of renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter (NBC1) activity by cholinergic agonists, ANG II, and acute acidosis (CO2) requires both Src family kinase (SFK) and classic MAPK pathway activation. The nonreceptor tyrosine kinase proline-rich tyrosine kinase 2 (Pyk2) couples discrete G protein-coupled receptor and growth factor receptor signaling to SFK activation. We examined the role of Pyk2-SFK interaction in coupling these stimuli to increased NBC1 activity in opossum kidney cells. Carbachol increased tyrosine autophosphorylation of endogenous Pyk2 and ectopically expressed wild-type Pyk2 and were abrogated by kinase-dead mutant (Pyk2-KD) overexpression. Pyk2 phosphorylation was calcium/calmodulin dependent, and Pyk2 associated with Src by means of SH2 domain interaction. Pyk2 phosphorylation and Pyk2-Src interaction by carbachol were mimicked by both ANG II and CO2. To correlate Pyk2 autophosphorylation and Pyk2-Src interaction with NBC activity, cotransporter activity was measured in untransfected cells and in cells overexpressing Pyk2-KD in the presence or absence of carbachol, ANG II, or CO2. In Pyk2-KD-overexpressing cells, the effect of carbachol, ANG II, and CO2 was abolished. We conclude that Pyk2 plays a central role in coupling carbachol, ANG II, and CO2 to increased NBC activity. This coupling is mediated by Pyk2 autophosphorylation and Pyk2-Src interaction.

carbachol; angiotensin II; acute acidosis; autophosphorylation; sodium-bicarbonate cotransporter; proline-rich tyrosine kinase 2


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

WE HAVE PREVIOUSLY CHARACTERIZED the regulation of Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter (NBC) activity in renal epithelial cells by carbachol, ANG II, and CO2 (16-18, 20). Interestingly, these diverse stimuli have been shown to share a number of common signaling requirements, including both Src family kinase (SFK) and classic MAPK pathway activation (14, 22). In the case of carbachol and ANG II, we have demonstrated a specific role for calcium/calmodulin in this regulation (Ruiz OS and Arruda JAL, unpublished observations, and Ref. 14). However, a common unifying mechanism whereby these diverse stimuli activate these common signaling intermediates and increase proximal tubule cell NBC activity has not been elucidated.

The nonreceptor tyrosine kinase (NRTK) proline-rich tyrosine kinase 2 (Pyk2) (2, 10), also referred to as related adhesion focal tyrosine kinase (1), cellular adhesion kinase-beta (26), and calcium-dependent tyrosine kinase (34), is known to interact with SFKs, an association that requires autophosphorylation and thereby plays an important role in coupling both G protein-coupled receptors (GPCR) and growth factor receptors to classic MAPK pathway activation in a number of cell types. Calcium-dependent Pyk2 activation and Src interaction have been demonstrated after GPCR stimulation by carbachol and ANG II (8). We therefore examined whether Pyk2 could play a similar role in the calcium-dependent carbachol and ANG II stimulation of NBC1 activity in renal epithelial cells.

The role of Pyk2 in epithelial cells has been incompletely explored (9, 11) and, to our knowledge, has not been examined in the kidney. Pyk2 exhibits renal expression (10, 12, 30) and has been immunohistochemically localized to the renal proximal tubule (12). We have recently reported, in preliminary form, the presence of endogenous Pyk2 in the opossum kidney (OK) proximal tubule cell line (6). In the present study, we examined both Pyk2 phosphorylation and Pyk2-SFK interaction for roles in the regulation of basolateral NBC activity in these cells. This cotransporter is a major determinant of HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> reabsorption by the proximal tubule and may serve as a prototype for the characterization of the role of Pyk2 in renal epithelial transport, especially the regulation of intracellular pH (pHi).

We have previously demonstrated a general role for G proteins in the regulation of proximal tubule cell NBC activity (19). More recently, we have shown that activation of specific GPCRs for both muscarinic cholinergic agonists (14) and ANG II (15) increase NBC activity by means of the sequential activation of Src family tyrosine kinases (SFKs) and the classic MAPK pathway. Although a general requirement for calcium/calmodulin has been demonstrated for cholinergic stimulation of NBC activity (16) and calcium is a known effector of many of angiotensin's cellular actions, the specific mechanisms coupling GPCR activation to SFK activation, and ultimately to increased NBC activity, have not been defined. We therefore sought to examine whether Pyk2 might play a role in these processes.

In addition to the GPCR-mediated processes above, acute acidosis has also been shown to activate both SFKs (22, 32, 33) and the classic MAPK pathway (22) in this cell type, thereby increasing NBC activity (22). We therefore also examined the role of Pyk2 in this unrelated, non-GPCR-mediated process.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents. The pH-sensitive fluorophore BCECF was obtained from Molecular Probes (Eugene, OR) as the membrane-permeable AM (BCECF-AM). Amiloride was purchased from Research Biochemicals (Natick, MA). Src-specific antibodies (GD11) were obtained from Upstate Biotechnology (Lake Placid, NY), as were the SFK and Src assay kits and ERK kinase kits employed herein. Phosphotyrosine-specific antibodies were obtained from Zymed (PY Plus; South San Francisco, CA) or BD Transduction Laboratories (RC20, Lexington, KY). Pyk2-specific monoclonal antibodies were also obtained from BD Transduction Laboratories. Rabbit polyclonal anti-Pyk2 phosphospecific antibodies (alpha -Pyk2-pTyr402) were obtained from Biosource (Camarillo, CA). Agarose-immobilized Src-SH2 domain peptides were purchased from Calbiochem (La Jolla, CA). Immunoblots were analyzed with a commercially available chemiluminescence detection system (Phototope) from New England Biolabs (Beverly, MA). All other immunoblotting reagents, including nitrocellulose membranes, were routinely obtained from Bio-Rad (Hercules, CA). Cell culture reagents, including serum and additives, were purchased from GIBCO BRL (Grand Island, NY). All other reagents, including carbachol, ANG II, the calmodulin antagonist N-(4-aminobutyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-13), and murine monoclonal antibodies directed against the c-myc epitope (MEQKLISEEDL, clone 9E10) (7) were obtained from Sigma (St. Louis, MO).

Cell culture. Mycoplasma-free American OK cells were obtained from the American Type Culture Collection (Rockville, MD) at passage 37 and were maintained in Eagle's minimum essential medium containing Earle's balanced salts and supplemented with 10% fetal bovine serum as described previously (14). Cells were routinely serum deprived for 24 h before and during testing and were typically preincubated with inhibitors for at least 30 min where appropriate.

Fluorometric assays of pHi and NBC activity. Confluent cell monolayers cultured on uncoated plastic coverslips were made quiescent, loaded with BCECF, and continuously monitored for pH-dependent changes in fluorescence at 37°C as described previously (14, 23). In brief, cells were perfused at 37°C with a Cl-free physiological solution [(in mM) 25 NaHCO<UP><SUB>3</SUB><SUP>−</SUP></UP>, 110 sodium gluconate, 5 potassium gluconate, 2 CaSO4, 0.5 MgSO4, 1 KH2PO4, 10 glucose, and 9 HEPES, pH 7.40] containing 1 mM amiloride to minimize the contributions of cellular Cl/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> and Na/H exchange activities at a rate of 20 ml/min. Extracellular pH was maintained constant at 7.40. After a stable basal fluorescence signal was established, Na removal by equimolar substitution with choline resulted in an immediate decrease in pHi and pH-sensitive BCECF fluorescence that rapidly and fully recovered on the reintroduction of Na. NBC activity was taken as the initial rate of pH recovery after the addition of NaHCO<UP><SUB>3</SUB><SUP>−</SUP></UP> and was calculated from the slope of the line drawn tangentially to the initial deflection over a period of 1 min. pH-sensitive BCECF fluorescence at 530 nm was routinely calibrated at the completion of each experiment in the presence of elevated extracellular potassium and the ionophore nigericin (to equilibrate pHi and extracellular pH). All measurements were performed by dual-wavelength monitoring and ratiometric analysis at pH-sensitive (490 nm) and -insensitive (440 nm) excitation wavelengths (F490/F440).

Src phosphorylation and kinase activity assays. Src phosphorylation was assessed by quantitative immunoblot analysis of whole cell lysates by using both Src-specific polyclonal antisera and recombinant monoclonal anti-phosphotyrosine antibodies (RC20) as described previously (14, 22). Src kinase activity was evaluated in parallel by using a commercially available immunoprecipitated kinase activity assay (Upstate Biotechnology, Lake Placid, NY) according to the manufacturer's recommendations. In brief, we tested the in vitro ability of Src immunoprecipiates to phosphorylate a synthetic oligopeptide substrate (KVEKIGEGTYGVVYK) corresponding to residues 6-20 of p34cdc2 (3). Samples were incubated in (in mM) 25 Tris · HCl (pH 7.2), 31.3 MgCl2, 25 MnCl2, 0.5 EGTA, and 0.5 DTT, as well as 62.5 µM Na3VO4 and 112.5 µM ATP containing 10 µCi [gamma -32P]ATP at 30°C for 10 min before the reaction was stopped by the addition of trichloroacetic acid. After application to P81 phosphocellulose paper, unincorporated radionuclides were eluted with 7.5% (vol/vol) phosphoric acid. Phosphotranferase activity was then assayed as specific 32P incorporation into the substrate by liquid scintillation counting.

ERK1/2 activity assay. Total ERK1/2 kinase activity was measured by using a commercially available nonradioactive in vitro immunoprecipitated kinase activity assay (Upstate Biotechnology) according to the manufacturer's recommendations. In brief, ERK1/2 immunoprecipitates prepared from whole cell lysates were tested for the ability to phosphorylate myelin basic protein in the presence of inhibitors of PKA, PKC (PKC inhibitor peptide), and calmodulin kinase II (R24571). The total concentration mixture consisted of (in mM) 15 MOPS, pH 7.2, 18.75 beta -glycerolphosphate, 18.75 MgCl2, 3.75 EGTA, 0.75 sodium orthovanadate, 0.75 DTT, and 112.5 ATP, and (in µM) 5 PKC inhibitor, 0.5 PKA inhibitor, and 0.5 compound R24571, as well as 20 mg of dephosphorylated myelin basic protein. Reactions were carried out at 30°C for 20 min. Five microliters of the reaction were resolved in 12% SDS-PAGE and probed with anti-pMBP. Carbachol and ANG II findings were also confirmed with a radioactive immunoprecipitated ERK1/2 activity assay as described previously (14).

Ectopic Pyk2 expression. Mammalian expression vectors encoding wild-type Pyk2 (Pyk2-WT) mutant (pCMV-Pyk2-WT) and a K457A-kinase-dead Pyk2 (Pyk2-KD) mutant (pCMV-Pyk2-KD) were the generous gift of Dr. J. Thomas Parsons (University of Virginia) and have been described previously (31). These vectors express full-length Pyk2-WT or Pyk2-KD fused to an NH2-terminal c-myc epitope tag (MEQKLISEEDL) (7). Transient gene transfer was achieved in subconfluent OK cells by using LipofectAMINE lipofection reagent (Life Technologies, Rockville, MD) according to the manufacturer's recommendations and as described previously (14). Transiently transfected cells were routinely tested within 48 h of gene transfer. Ectopic Pyk2-WT or Pyk2-KD (K457A) expression was routinely confirmed by immunoblot analysis with the 9E10 murine monoclonal antibody directed against the c-myc epitope tag (7). For fluorometric assay, stable transfection of OK cells with Pyk2-KD was performed by using the same method and was selected with 400 µg/ml G418.

Phoshorylation and immunoprecipitation. Whole cell lysates (500 µg) were incubated with antibodies specific for Pyk2, phosphotyrosine, or Src for 6 h at 4°C. The resulting immunocomplexes were precipitated with immobilized protein G/protein A (Calbiochem). Constituent proteins were eluted from these immunocomplexes by boiling for 10 min in 2× SDS sample buffer and were resolved by denaturing PAGE before transfer to nitrocellulose for immunoblotting. To examine the effect of W-13 on Pyk2 phosphorylation, quiescent cells transiently transfected with Pyk2-WT were treated with 100 µM of W-13 for 30 min and stimulated with carbachol. The cells were lysed and 500 µg of lysates were immunoprecipitated with anti-Pyk2 or anti-phosphotyrosine and immunoblotted with anti-phosphotyrosine and anti-Pyk2, respectively.

Pyk2 autophosphorylation was determined by probing an equal amount of carbachol stimulated and paired control cell lysates with alpha Pyk2-pTyr402, an antibody specific to the Pyk2 autophosphorylation site. Pyk2 autophosphorylation was also measured in Pyk2-WT and Pyk2-KD overexpresssing cells with the same method.

Immunoblot analysis. Whole cell lysates were routinely prepared in radioimmunoprecipitation assay buffer (50 mM Tris · Cl, 1% Nonidet P-40, 0.25% Na-deoxycholate, 150 mM NaCl, and 1 mM EDTA) supplemented with both protease inhibitor and phosphatase inhibitor cocktails (Sigma). Lysate proteins were electrophoretically resolved and transferred to nitrocellulose for immunoblotting as described previously (14). After incubation in Tris-buffered saline with 0.1% Tween 20, 20 mM Tris · Cl, and 500 mM NaCl containing 10% (wt/vol) immunoblot grade nonfat dry milk for 1 h at room temperature to block nonspecific binding, primary antibodies were routinely incubated.

Pyk2-Src coprecipitation assays. Pyk2-Src interaction was assayed by precipitating 500 µg of stimulated and unstimulated Pyk2-WT-overexpressing cell lysates with alpha -Src or alpha -Pyk2 antibodies. The eluted proteins were analyzed by immunoblotting with alpha -Pyk2 or anti-Src, respectively. Coprecipitation with SH2 domain linked to protein A-agarose was also performed.

Statistical analysis. Densitometric analysis of Western blots was carried out by using NIH Image software. All data are expressed as means ± SE for a series of n experiments. Student's t-tests or ANOVA were used. P values <0.05 were considered to represent significant differences.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Cholinergic stimulation of Src kinase activity is calcium/calmodulin dependent. We have previously demonstrated a general requirement for increased intracellular calcium in the stimulation of NBC activity by both carbachol and ANG II. We have also shown that carbachol- and ANG II-stimulated NBC activity share a common requirement for sequential SFK and classic MAPK pathway activation (14, 21). The mechanism whereby intracellular calcium is coupled to these other signaling intermediates, however, has not been defined. The ubiquitous calcium-binding protein calmodulin is known to couple intracellular calcium to the activation of a number of signaling intermediates, including SFKs. Thus, to better define the relationship between intracellular calcium and other signaling intermediates implicated in NBC regulation, we examined the calcium chelator BAPTA and the calmodulin antagonist W-13 for the ability to prevent activation of both SFKs and the classic MAPK pathway. As shown in Table 1, both carbachol and ANG II increased the activities of SFK and Src, as well as ERK, the distal element of the classic MAPK pathway. We have examined the effect of ANG II, carbachol, or 10% CO2 on MAPK activity by using ERK1/2 immunoprecipitates for their ability to phosphorylate myelin basic protein. As can be seen in Fig. 1, ANG II, carbachol, or 10% CO2 all increased ERK1/2 activity. These effects were inhibited by intracellular calcium chelation (+BAPTA), as well as by calmodulin antagonism (+W-13). Neither BAPTA nor W-13 had a significant effect on the basal activities of these signaling intermediates, suggesting that neither agent directly inhibits the measured kinase activities.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Calcium/calmodulin dependence of cholinergic- and ANG II-stimulated Src and ERK1/2 kinase activation



View larger version (58K):
[in this window]
[in a new window]
 
Fig. 1.   BAPTA and W-13 prevent angiotension II (ANG II), carbachol, and CO2-induced MAPK activity. Quiescent cells were treated with ANG II, carbachol, or CO2 in the presence or absence of BAPTA or W-13. Cells were lysed and 1 mg of lysates was immunoprecipitated with alpha -MAPK-agarose. The immunoprecipitated enzyme is used to phosphorylate myelin basic protein (MBP). Phosphorylated MBPs were run in 12% SDS-PAGE and probed with alpha -pMBP. BAPTA and W-13 abrogated ANG II-, carbachol-, and CO2-induced MAPK activity. Values are from a single experiment that was repeated 3 times with identical results. IB, immunoblotted.

Cholinergic stimulation increases endogenous Pyk2 tyrosine phosphorylation. Cholinergic stimulation of SFK activation is coupled to calcium/calmodulin and Pyk2 activation in PC12 cells. Similar coupling has been observed for ANG II stimulation in myocardial cells. We therefore studied a possible role for Pyk2 in coupling intracellular calcium to the regulation of NBC activity in renal epithelial cells. As depicted in Fig. 2A, Pyk2 is strongly expressed in OK cells. Cholinergic stimulation increased tyrosine phosphorylation of a protein that comigrates with Pyk2 (Fig. 2B) but not total Pyk2 abundance in quiescent OK cells stimulated with 100 µM carbachol for 5 min.


View larger version (48K):
[in this window]
[in a new window]
 
Fig. 2.   Cholinergic stimulation of endogenous Pyk2 tyrosine phosphorylation. Both carbachol (100 µM, 5 min)-stimulated and -paired, unstimulated control cell lysates were immunoblotted with both Pyk2- and phosphotyrosine-specific antibodies. A: immunoreactive band of the appropriate size (~110 kDa) was routinely detected with Pyk2-selective antibodies, and this band comigrated with the corresponding Pyk2 band in murine brain control lysates. B: tyrosine phosphorylation of a protein that comigrates with Pyk2 was detected with phosphotyrosine (pTyr)-specific antibodies and was observed in both stimulated and unstimulated cell lysates. Phosphorylation was increased after cholinergic stimulation. OK, opossum kidney.

Ectopic expression of both Pyk2-WT and Pyk2-KD in OK cells and Pyk2 phosphorylation. To determine whether a Pyk2 catalytic site plays a role in phosphorylation and association, we transiently transfected OK cells with Pyk2-WT and Pyk2-KD. After 48 h of transfection, cells were lysed and Pyk2 were analyzed by using Pyk2 and c-myc antibodies. An intense band of ~110 kDa for c-myc was noted in Pyk2-WT and Pyk2-KD transfectants, confirming successful overexpression because Pyk2-WT and Pyk2-KD were both targeted with c-myc epitope (Fig. 3A). Phosphorylation assays were also performed on cells overexpressing Pyk2-WT and Pyk2-KD with and without carbachol stimulation. Figure 3B shows that Pyk2 phosphorylation of cells transfected with Pyk2-WT was increased by carbachol compared with control, and transfection of Pyk2-KD prevented phosphorylation. Quantitative analysis of Pyk2 phosphorylation showed a significant increase in phosphorylation by carbachol (Fig. 3C).


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 3.   Cholinergic stimulation of Pyk2 phosphorylation. Overexpression of wild-type Pyk2 (Pyk2-WT) enhances Pyk2-phosphorylation and kinase-dead Pyk2 (Pyk2-KD) prevents phosphorylation. A: OK cells were grown to 80% confluency and transfected with Pyk2-WT (+Pyk2-WT) or Pyk2-KD (+Pyk2-KD) with the lipid-mediated transfection method. Anti-c-myc detected an approx 110-kDa protein in transfected cells, which is not present in untransfected cells. B: quiescent untransfected cells and cells transiently transfected with Pyk2-WT or Pyk2-KD were treated with carbachol and 500 µg of cell lysates were immunoprecipitated (IP) with alpha -ptyr and RC20 and immunoblotted with alpha -Pyk2 or vice versa. Carbachol increases phospho-Pyk2 and overexpression of Pyk2-KD diminishes phosphorylation. C: quantitative analysis of Pyk2 phosphorylation obtained by using densitometric analysis of 5 independent paired experiments showed a significant increase of Pyk2 phosphorylation by carbachol. Baseline phosphorylation of endogenous Pyk2 is so low that it did not permit quantitative analysis.

Cholinergic stimulation increases Pyk2 autophosphorylation. Increased phosphorylation was shown in Fig. 3. To examine whether autophosphorylation is involved, we used Pyk2-pTyr402 antibodies to detect phosphorylation of Tyr402 residue. Figure 4A shows that endogenous Pyk2 is phosphorylated by cholinegic stimulation. The same result was obtained in cells overexpressing Pyk2-WT, and autophosphorylation was completely abolished in Pyk2-KD-overexpressing cells (Fig. 4B).


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 4.   Cholinergic stimulation increased Pyk2 autophosphorylation. A: 50 mg of carbachol-stimulated and -paired, unstimulated untransfected OK lysates were probed with antibody specific for the Pyk2 autophosphorylation site (alpha Pyk2-pTyr402). Carbachol induced phosphorylation of endogenous Pyk2-Tyr402. B: similar results were obtained with cells overexpressing Pyk2-WT. Overexpression of Pyk2-KD prevented Pyk2-Tyr402 phosphorylation. Values are from a single, paired experiment that was repeated 3 times with identical results.

Pyk2 autophosphorylation requires calcium/calmodulin. To examine the calcium/calmodulin dependence of Pyk2 autophosphorylation, we preincubated cells overexpressing Pyk2-WT with W-13 (100 µM × 30 min) before carbachol stimulation. At 5 min, cells were harvested and lysed. Whole cell lysates were precipitated with anti-Pyk2 or anti-phosphotyrosine and probed with anti-phosphotyrosine and anti-Pyk2, respectively. There was an increase in Pyk2 phosphorylation with carbachol, but this effect was totally blocked with W-13 (Fig. 5A), consistent with a proximal effector function for calcium/calmodulin in Pyk2 phosphorylation. Identical results were observed for endogenous Pyk2 (Fig. 5B).


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 5.   Cholinergic stimulation of Pyk2-Tyr402 phosphorylation is calcium/calmodulin dependent. A: cells overexpressing Pyk2-WT were serum deprived for 24 h, incubated with W-13 for 30 min, and treated with carbachol. Cell lysates (500 mg) were immunoprecipitated with alpha -pTyr and RC20 and probed with anti-Pyk2. The same amount of cell lysates were immunoprecipitated with anti-Pyk2 and blotted with alpha -pTyr. Carbachol increased the amount of phosphorylated Pyk2, and this effect was prevented by calmodulin antagonist W-13. B: identical results were observed for endogenous Pyk2. A representative blot of 3 experiments is shown.

Autophosphorylated Pyk2 physically associates with Src. In previous experiments, Pyk2 autophosphorylation (Pyk2-Tyr402) in response to carbachol stimulation was shown, and the result was consistent with increased total tyrosine phosphorylation of Pyk2 in response to carbachol. Thus we sought to determine whether autophosphorylation plays a role in Pyk2 and Src association as previously shown in PC12 cells. Cells overexpressing Pyk2-WT were stimulated with carbachol, and Src-Pyk2 association was analyzed by coprecipitation assays. Figure 6A shows that in the presence of carbachol, there was an increased Src-Pyk2 association. This association was shown to be mediated by Src-SH2 domains. Pyk2 was found to physically interact with Src under conditions associated with Pyk2 autophosphorylation. The ability of immobilized Src-SH2 domains to mimic Src in coprecipitating Pyk2 suggests specific contributions by SH2-phosphotyrosine interactions. Figure 6B shows that carbachol increases SH2-phospho-Pyk2 interaction compared with unstimulated cells. This association was enhanced in cells overexpressing Pyk2-WT and was prevented in cells expressing Pyk2-KD.


View larger version (30K):
[in this window]
[in a new window]
 
Fig. 6.   The SH2 domain of Src is sufficient for association with Pyk2. A: quiescent cells were stimulated with carbachol and lysed, and 500 µg of lysates from both unstimulated and carbachol-stimulated cells expressing ectopic Pyk2-WT were immunoprecipitated with anti-Src or anti-Pyk2 and vice versa. Immunoprecipitated proteins were probed with anti-Pyk2 or anti-Src, respectively. Increased physical association of Pyk2 and Src is observed in the presence of carbachol. B: 500-mg lysates of untransfected cells and cells transfected with Pyk2-WT and Pyk2-KD were precipitated with Src-SH2 domain agarose conjugate and probed with anti-Pyk2. A 110-kDa protein detected with Pyk2-specific antibodies showed that Pyk2 and Src association is mediated by Src-SH2 domain. Association is observed in untransfected cells treated with carbachol. This effect is enhanced by overexpression of Pyk2-WT. Overexpression of Pyk2-KD disrupts this interaction, showing that Pyk2 phosphorylation is required. Values are from a single, paired experiment that was repeated 3 times.

We have previously shown that 10% CO2 increased SFK activity (19), and this effect was mimicked by 100 µM carbachol and 0.1 nM ANG II. Also depicted in Fig. 1 is that these diverse stimuli increased ERK activity in parallel. To determine whether the association between Src and Pyk2 was restricted to carbachol stimulation, we studied the effects of 0.1 nM ANG II and 10% CO2 on Pyk2-Src interaction. Figure 7 shows that similar to carbachol, both ANG II and 10% CO2 also increased Pyk2 phosphorylation and Src-Pyk2 association.


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 7.   ANG II, carbachol, and CO2 increase Pyk2 phosphorylation and Src-Pyk2 association. Quiescent cells overexpressing Pyk2-WT were treated with ANG II, carbachol, or CO2. Immunoprecipitation with anti-Pyk2 and probing with anti-phosphotyrosine shows increased Pyk2 phosphorylation in the presence of Src, ANG II, carbachol, and CO2. The first antibody was stripped from the membrane and probed with anti-Src, and the result showed that phosphorylated Pyk2 interacts with Src. This result showed that Pyk2 and Src interaction coupled diverse stimuli to increased NBC activity in OK cells. Values are from a single, paired experiment that was repeated 3 times.

Disruption of Pyk2 function abrogates stimulated, but not basal, NBC activity. We have previously shown that OK cells express the proximal tubule NBC1 isoform (15), and NBC activity is increased by ANG II, carbachol, and 10% CO2 (14, 15, 20). We have shown here that Pyk2-KD overexpression decreased both Pyk2 autophosphorylation and Src-Pyk2 association in carbachol-stimulated cells. As an indirect test of the hypothesis that Pyk2 activation and Pyk2-Src association play a central role in the transduction of diverse extracellular signals that serve to increase NBC activity, we examined ectopic Pyk2-KD expression for the ability to attenuate the stimulatory effects of carbachol (10 µM), ANG II (0.1 nM), and acute acidosis (10% CO2). Table 2 shows that Pyk2-KD overexpression prevented the effect of carbachol, ANG II, or 10% CO2 to stimulate NBC activity without altering baseline activity.

                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Central role for Pyk2 in the stimulation of NBC1 activity by ANG II, carbachol, and CO2


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Pyk2 is a recently described NRTK with structural similarities to focal adhesion kinase (FAK) that associates with SFK (2, 5, 8) through phosphorylation of Tyr402 and creates a binding site for SH2 domains of SFKs (29). Despite close structural homology to FAK, which also interacts with Src, Pyk2 is activated by various stimuli and has been shown to couple both GPCRs and growth factor receptors to classic MAPK pathway activation (8). Pyk2 has been shown to mediate different functions from those associated with FAK in a number of cell types (31). Pyk2 is also distinguished from FAK by means of its association with stimuli capable of increasing free intracellular calcium, activation of PKC, and exposure to stress factors (28, 29).

Although Pyk2 is predominantly expressed in the central nervous system and best characterized in PC12 cells, it is expressed in the kidney (10, 12, 30) and has been immunohistochemically localized to the proximal tubule (12). In the present work, we have established the renal epithelial cell expression of Pyk2, as well as its function in coupling diverse stimuli to NBC activation and signal transduction mechanisms associated with NBC activation in an OK renal epithelial cell line. We demonstrated that calcium/calmodulin and the classic MAPK pathway serve as important signaling effectors proximal and distal to Pyk2-SFK interaction, respectively. This also showed a common requirement of calcium/calmodulin and Pyk2-SFK interaction in the cholinergic and ANG II stimulation of epithelial cell NBC activity.

The presence of endogenous Pyk2 and its activation by acute acidosis in the OK renal epithelial cell line have also previously been reported in preliminary form (27), but Pyk2 activation in this cell type has not been characterized and its functional consequences are not known. In the present work, we confirmed the endogenous expression of Pyk2 in OK cells and have shown that this NRTK plays an important role in coupling the effect of carbachol, ANG II, and acute acidosis to SFK activation and ultimately to increased NBC activity. To our knowledge, this represents the first description of a functional interaction between Pyk2 and Src in renal epithelial cells.

Pyk2 autophosphorylation plays an important role in the transduction of diverse GPCR signals (5, 8) and was recently implicated in the translocation of GLUT4 (25). Both carbachol (4, 8-10) and ANG II (13, 24) have been shown to stimulate Pyk2 activation in a variety of cells types. In cardiac fibroblasts, this activation has been shown to be calcium/calmodulin sensitive (13) and the first description of Pyk2 activation by acute acidosis. Our findings suggest a specific mechanism whereby SFK activation may be coupled to diverse GPCR and non-GPCR stimuli through Pyk2 and show a central role of Pyk2 in transducing a number of physiologically important signals that regulate pHi by means of coincident effects on NBC.

Ectopic expression of the kinase-inactive K457A-Pyk2 mutant (Pyk2-KD) completely abrogated Pyk2 tyrosine phosphorylation in both stimulated and unstimulated cells. This mutant contains a single Lys for Ala mutation in the ATP binding site of the kinase domain of Pyk2 (31). The absence of detectable tyrosine phosphorylation for both unstimulated and stimulated cells ectopically expressing Pyk2-KD is compatible with the known requirement for an intact kinase domain and the absence of Pyk2 Tyr402 phosophorylation with Pyk2-KD is consistent with this result and emphasizes the importance of autophosphorylation. Overexpression of Pyk2-KD totally prevented Pyk2-Src association by means of the SH2 domain. Taken together, these findings suggest that Pyk2 autophosphorylation is required for both activity and interaction with Src. These findings are compatible with those reported previously in other cell types (31).

We have previously shown that the glucocorticoid stimulation of NBC activity was not inhibited by overexpression of the negative regulator of Src, Csk (23), indicating that the effect of ANG II, carbachol, and CO2 on the Src/MAPK pathway is specific. The exact mechanism whereby acute changes in pHi activate NRTKs, such as Pyk2 and Src, is not known, but acute acidosis has been variably associated with both increased and decreased free intracellular calcium content in a variety of cell types. A previous study has suggested that proximal tubule cell Src activation by acute intracellular acidosis is calcium independent (33). In our laboratory, CO2 stimulation of NBC1 activity appears to be calcium/calmodulin dependent (Ruiz OS and Arruda JAL, unpublished observations), suggesting that this may serve as a common mechanism of initiating the signaling cascade examined herein and culminating in increased NBC activity. The present studies show that the ability of both ANG II and CO2 to stimulate ERK1/2 activity was also inhibited by BAPTA and W-13 (Fig. 1). The ability of CO2 to mimic the effects of ANG II and carbachol in activating the calcium-dependent NRTK Pyk2 is compatible with this hypothesis.

In the present work, we have attempted to define the molecular basis for SFK activation and signaling in the stimulation of NBC activity by acute acidosis, cholineric agonists, and ANG II. These stimuli have been individually shown to signal by means of both SFK-dependent and SFK-independent mechanisms in a variety of cell types. It is therefore of considerable interest that these diverse stimuli share a common mechanism of NBC activation involving both SFK activation and SFK-MAPK coupling in renal epithelial cells (6, 21). We have clearly demonstrated that Pyk2-SFK interaction serves as a unifying coupling mechanism for these diverse stimuli and thereby plays an important role in the integration of a wide range of signals known to increase epithelial cell NBC activity. In addition to providing important mechanistic insights into the regulation of epithelial cell NBC activity, our findings provide new regulatory and functional insights into the role of Pyk2 in these cells. We have demonstrated the novel activation of Pyk2 by acute acidosis, and our findings also suggest a novel functional role for this NRTK in the regulation of pHi. A common requirement for Pyk2 in both the activation of SFKs and the subsequent stimulation of NBC activity is compatible with a pivotal role for Pyk2-SFK coupling in the regulation of vectorial ion transport in this cell type.


    ACKNOWLEDGEMENTS

The authors acknowledge the technical assistance of Yi-Yong Qiu, Fely Kear, and Dolores L. Mahmud.


    FOOTNOTES

This work was supported in part by grants-in-aid from local affiliates of the National Kidney Foundation and the American Heart Association, as well as by the Merit Review Program Awards from the US Department of Veterans Affairs. Portions of this work were presented in preliminary form at the 33rd Annual Meeting of the American Society of Nephrology on October 14, 2000 in Toronto, Ontario, Canada (6).

Address for reprint requests and other correspondence: J. A. L. Arruda, Rm. 418W CSN, Section of Nephrology (M/C 793), Univ. of Illinois at Chicago, 820 South Wood St., Chicago, IL 60612-73155 (E-mail JAArruda{at}uic.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

May 7, 2002;10.1152/ajprenal.00338.2001

Received 9 November 2001; accepted in final form 30 April 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Avraham, S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE, and Avraham H. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem 270: 27742-27751, 1995[Abstract/Free Full Text].

2.   Blaukat, A, Ivankovic-Dikic I, Gronroos E, Dolfi F, Tokiwa G, Vouri K, and Dikic I. Adaptor proteins Grb2 and Crk couple Pyk2 with activation of specific mitogen-activated protein kinase cascades. J Biol Chem 274: 14893-14901, 1998[Abstract/Free Full Text].

3.   Cheng, HC, Nishio H, Hatase O, Ralph S, and Wang JH. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem 267: 9248-9256, 1992[Abstract/Free Full Text].

4.   Derkinderen, P, Siciliano J, Toutant M, and Girault JA. Differential regulation of FAK and PYK2/Cakbeta, two related tyrosine kinases, in rat hippocampal slices: effects of LPA, carbachol, depolarization and hyperosmolarity. Eur J Neurosci 10: 1667-1675, 1998[ISI][Medline].

5.   Dikic, I, Tokiwa G, Lev S, Courtneidge SA, and Schlessinger J. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550, 1996[ISI][Medline].

6.   Espiritu, DJD, Bernardo AA, Robey RB, Mahmud DL, and Arruda JAL Ca2+/CaM kinase dependent proline rich tyrosine kinase 2 (PYK2)/SRC interaction mediates carbachol stimulation of Na+/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter (NBC) (Abstract). J Am Soc Nephrol 11: 411A, 2000.

7.   Evan, GI, Lewis GK, Ramsay G, and Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol 5: 3610-3616, 1985[ISI][Medline].

8.   Felsch, JS, Cachero TG, and Peralta EG. Activation of protein tyrosine kinase PYK2 by the m1 muscarinic acetylcholine receptor. Proc Natl Acad Sci USA 95: 5051-5156, 1998[Abstract/Free Full Text].

9.   Keely, SJ, Calandrella SO, and Barrett KE. Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca(2+), PYK-2, and p60(src). J Biol Chem 275: 12619-12625, 2000[Abstract/Free Full Text].

10.   Lev, S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, and Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature 376: 737-745, 1995[ISI][Medline].

11.   Li, X, and Earp HS. Paxillin is tyrosine-phosphorylated by and preferentially associates with the calcium-dependent tyrosine kinase in rat liver epithelial cells. J Biol Chem 272: 14341-14348, 1997[Abstract/Free Full Text].

12.   Mitaka, T, Shindoh M, Mochizuki Y, Sasaki H, Ishino M, Matsuya M, Ninomiya T, and Sasaki T. Restricted expression of cell adhesion kinase-beta in rat tissues. Am J Pathol 150: 267-281, 1997[Abstract].

13.   Murasawa, S, Mori Y, Nozawa Y, Masaki H, Maruyama K, Tsutsumi Y, Moriguchi Y, Shibasaki Y, Tanaka Y, Iwasaka T, Inada M, and Matsubara H. Role of calcium-sensitive tyrosine kinase Pyk2/CAKbeta /RAFTK in angiotensin II induced Ras/ERK signaling. Hypertension 32: 668-675, 1998[Abstract/Free Full Text].

14.   Robey, RB, Ruiz OS, Baniqued J, Mahmud D, Espiritu DJD, Bernardo AA, and Arruda JAL SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransport activity in renal epithelial cells. Am J Physiol Renal Physiol 280: F844-F850, 2001[Abstract/Free Full Text].

15.   Robey, RB, Ruiz OS, Espiritu DJD, Ibanez VC, Kear FT, Noboa OA, Bernardo AA, and Arruda JAL Angiotensin II stimulation of renal epithelial cell Na/HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> contransport activity: a central role for Src family kinase/classic MAPK pathway coupling. J Membr Biol 187: 1-11, 2002[ISI][Medline].

16.   Ruiz, OS, Qiu YY, Cardoso LR, and Arruda JAL Regulation of the renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. VII. Mechanism of the cholinergic stimulation. Kidney Int 51: 1069-1077, 1997[ISI][Medline].

17.   Ruiz, OS, Qiu YY, Cardoso LR, and Arruda JAL Regulation of the renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. IX. Modulation by insulin, epidermal growth factor and carbachol. Regul Pept 77: 155-161, 1998[ISI][Medline].

18.   Ruiz, OS, Qiu YY, Wang LJ, and Arruda JAL Regulation of the renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. IV. Mechanisms of the stimulatory effect of angiotensin II. J Am Soc Nephrol 6: 1202-1208, 1995[Abstract].

19.   Ruiz, OS, Qiu YY, Wang LJ, and Arruda JALA Regulation of renal cortical Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. II. Role of G proteins. Am J Physiol Renal Fluid Electrolyte Physiol 268: F461-F467, 1995[Abstract/Free Full Text].

20.   Ruiz, OS, Qiu YY, Wang LJ, Cardoso LR, and Arruda JAL Regulation of renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. VIII. Mechanism of stimulatory effect of respiratory acidosis. J Membr Biol 162: 201-208, 1998[ISI][Medline].

21.   Ruiz, OS, Qiu YY, Wang LJ, Robey RB, and Arruda JAL The classic MAPK PATHWAY: a common mediator of Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter (NBC) activation by CO2, AII and carbachol (Abstract). J Am Soc Nephrol 9: 12A, 1998.

22.   Ruiz, OS, Robey RB, Qiu YY, Wang LJ, Li CJ, Ma J, and Arruda JAL Regulation of the renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. XI. Signal transduction underlying CO(2) stimulation. Am J Physiol Renal Physiol 277: F580-F586, 1999[Abstract/Free Full Text].

23.   Ruiz, OS, Wang LJ, Pahlavan P, and Arruda JAL Regulation of renal Na-HCO<UP><SUB>3</SUB><SUP>−</SUP></UP> cotransporter. III. Presence and modulation by glucocorticoids in primary cultures of the proximal tubule. Kidney Int 47: 1669-1676, 1995[ISI][Medline].

24.   Sabri, A, Govindarajan G, Griffin TM, Byron KL, Samarel AM, and Lucchesi PA. Calcium- and protein kinase C-dependent activation of the tyrosine kinase PYK2 by angiotensin II in vascular smooth muscle. Circ Res 83: 841-851, 1998[Abstract/Free Full Text].

25.   Sajan, MP, Bandyopadhyay G, Kanoh Y, Standaert ML, Quon MJ, Reed BC, Dikic I, and Farese RV. Sorbitol activates atypical protein kinase C and GLUT4 glucose transporter translocation/glucose transport through proline-rich tyrosine kinase-2, the extracellular signal-regulated kinase pathway and phospholipase D. Biochem J 362: 665-674, 2002[ISI][Medline].

26.   Sasaki, H, Nagura K, Ishino M, Tobioka H, Kotani K, and Sasaki T. Cloning and characterization of cell adhesion kinase beta, a novel protein-tyrosine kinase of the focal adhesion kinase subfamily. J Biol Chem 270: 21206-21219, 1995[Abstract/Free Full Text].

27.   Sato, S, Tsuganezawa H, Preisig PA, and Alpern RJ. Incubation of OKP cells in acid media induces Pyks phosphorylation (Abstract). J Am Soc Nephrol 10: 8A, 1999.

28.   Sieg, DJ, Ilic D, Jones KC, Damsky H, Hunter T, and Schlaepfer DD. Intracellular acidosis activates c-Src. EMBO J 17: 5933-5947, 1998[Abstract/Free Full Text].

29.   Tokiwa, G, Dikic I, Lev S, and Schlessinger J. Activation of Pyk2 by stress signals and coupling with JNK signaling pathway. Science 273: 792-793, 1996[Abstract].

30.   Xiong, WC, Macklem M, and Parsons JT. Expression and characterization of splice variants of PYK2, a focal adhesion kinase-related protein. J Cell Sci 111: 1981-1991, 1998[Abstract/Free Full Text].

31.   Xiong, WC, and Parsons JT. Induction of apoptosis after expression of PYK2, a tyrosine kinase structurally related to focal adhesion kinase. J Cell Biol 139: 529-539, 1997[Abstract/Free Full Text].

32.   Yamaji, Y, Amemiya M, Cano A, Preisig PA, Miller RT, Moe OW, and Alpern RJ. Overexpression of csk inhibits acid-induced activation of NHE-3. Proc Natl Acad Sci USA 92: 6274-6278, 1995[Abstract].

33.   Yamaji, Y, Tsuganezawa H, Moe OW, and Alpern RJ. Intracellular acidosis activates c-Src. Am J Physiol Cell Physiol 272: C886-C893, 1997[Abstract/Free Full Text].

34.   Yu, H, Yu H, Li X, Marchetto GS, Dy R, Hunter D, Calvo B, Dawson TL, Wilm M, Anderegg RJ, Graves LM, and Earp HS. Activation of a novel calcium-dependent protein-tyrosine kinase. Correlation with c-Jun N-terminal kinase but not mitogen-activated protein kinase activation. J Biol Chem 271: 29993-29998, 1996[Abstract/Free Full Text].


Am J Physiol Renal Fluid Electrolyte Physiol 283(4):F663-F670